AURO-EMTRICITABINE-TENOFOVIR
Identification of Auro-Emtricitabine-Tenofovir
No description |
Google image searchProduct monograph
Active ingredients
tenofovir disoproxil fumarate, 300 MG
emtricitabine, 200 MG
DIN: 02490684
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: AURO PHARMA INC
Date: 01-MAR-2023
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR03 — TENOFOVIR DISOPROXIL AND EMTRICITABINE (ATC/DDD)
Reference brand drug: Truvada
Pharmaceutical standard: MFR
External Links for Auro-Emtricitabine-Tenofovir
Search on Google
- Auro-Emtricitabine-Tenofovir side effects
- Auro-Emtricitabine-Tenofovir dosage
- tenofovir disoproxil fumarate side effects
- tenofovir disoproxil fumarate dosage
- emtricitabine side effects
- emtricitabine dosage
Auro Pharma Inc
Go to Auro Pharma website to see drug product details. Sometimes you can find auro-emtricitabine-tenofovir photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.